Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Intangible Assets
ÂĄ354.4m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
5%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Intangible Assets
ÂĄ177.4m
CAGR 3-Years
162%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Intangible Assets
ÂĄ279.1m
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
5%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Intangible Assets
ÂĄ4.2B
CAGR 3-Years
112%
CAGR 5-Years
64%
CAGR 10-Years
36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Intangible Assets
ÂĄ593.5m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Intangible Assets
ÂĄ28m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Intangible Assets?
Intangible Assets
354.4m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Intangible Assets amounts to 354.4m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
5%

Over the last year, the Intangible Assets growth was -8%. The average annual Intangible Assets growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been -9% over the past three years , -4% over the past five years , and 5% over the past ten years .

Back to Top